Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;181(7):1005-1027.
doi: 10.1111/bph.16239. Epub 2023 Nov 10.

Trilobatin attenuates cerebral ischaemia/reperfusion-induced blood-brain barrier dysfunction by targeting matrix metalloproteinase 9: The legend of a food additive

Linying Feng  1   2 , Yeli Li  1   2 , Mu Lin  1   2 , Dianyou Xie  1   2 , Yunmei Luo  1   2 , Yuandong Zhang  2 , Zhixu He  3 , Qihai Gong  1   2 , Zhu Yi Zhun  1 , Jianmei Gao  1   2
Affiliations
Free article

Trilobatin attenuates cerebral ischaemia/reperfusion-induced blood-brain barrier dysfunction by targeting matrix metalloproteinase 9: The legend of a food additive

Linying Feng et al. Br J Pharmacol. 2024 Apr.
Free article

Abstract

Background and purpose: Blood-brain barrier (BBB) breakdown is one of the crucial pathological changes of cerebral ischaemia-reperfusion (I/R) injury. Trilobatin (TLB), a naturally occurring food additive, exerts neuroprotective effects against cerebral I/R injury as demonstrated in our previous study. This study was designed to investigate the effect of TLB on BBB disruption after cerebral I/R injury.

Experimental approach: Rats with focal cerebral ischaemia caused by transient middle cerebral artery occlusion were studied along with brain microvascular endothelial cells and human astrocytes to mimic BBB injury caused by oxygen and glucose deprivation/reoxygenation (OGD/R).

Key results: The results showed that TLB effectively maintained BBB integrity and inhibited neuronal loss following cerebral I/R challenge. Furthermore, TLB increased tight junction proteins including ZO-1, Occludin and Claudin 5, and decreased the levels of apolipoprotein E (APOE) 4, cyclophilin A (CypA) and phosphorylated nuclear factor kappa B (NF-κB), thereby reducing proinflammatory cytokines. TLB also decreased the Bax/Bcl-2 ratio and cleaved-caspase 3 levels along with a reduced number of apoptotic neurons. Molecular docking and transcriptomics predicted MMP9 as a prominent gene evoked by TLB treatment. The protective effects of TLB on cerebral I/R-induced BBB breakdown was largely abolished by overexpression of MMP9, and the beneficial effects of TLB on OGD/R-induced loss of BBB integrity in human brain microvascular endothelial cells and astrocyte co-cultures was markedly reinforced by knockdown of MMP9.

Conclusions and implications: Our findings reveal a novel property of TLB: preventing BBB disruption following cerebral I/R via targeting MMP9 and inhibiting APOE4/CypA/NF-κB axis.

Keywords: apolipoprotein E 4; blood brain barrier; cerebral ischaemia/reperfusion; matrix metalloproteinase; tight junction; trilobatin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

REFERENCES

    1. Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. Softwarex, 1-2(C), 19-25. https://doi.org/10.1016/j.softx.2015.06.001
    1. Alexander, S. P. H., Fabbro, D., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Southan, C., Davies, J. A., Beuve, A., Brouckaert, P., Bryant, C., Burnett, J. C., Farndale, R. W., Friebe, A., Garthwaite, J., Hobbs, A. J., Jarvis, G. E., Kuhn, M., MacEwan, D., Monie, T. P., Potter, L. R., Schmidt, H. H. H. W., & Waldman, S. A. (2021). THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Catalytic receptors. British Journal of Pharmacology, 178, S264-S312. https://doi.org/10.1111/bph.15541
    1. Alexander, S. P. H., Roberts, R. E., Broughton, B. R. S., Sobey, C. G., George, C. H., Stanford, S. C., Cirino, G., Docherty, J. R., Giembycz, M. A., Hoyer, D., Insel, P. A., Izzo, A. A., Ji, Y., MacEwan, D. J., Mangum, J., Wonnacott, S., & Ahluwalia, A. (2018). Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of pharmacology. British Journal of Pharmacology, 175(3), 407-411. https://doi.org/10.1111/bph.14112
    1. Amruta, N., & Bix, G. (2021). ATN-161 ameliorates ischemia/reperfusion-induced oxidative stress, fibro-inflammation, mitochondrial damage, and apoptosis-mediated tight junction disruption in bEnd.3 cells. Inflammation, 44(6), 2377-2394. https://doi.org/10.1007/s10753-021-01509-9
    1. Arnaud, L., Benech, P., Greetham, L., Stephan, D., Jimenez, A., Jullien, N., García-González, L., Tsvetkov, P. O., Devred, F., Sancho-Martinez, I., Izpisua Belmonte, J. C., Baranger, K., Rivera, S., & Nivet, E. (2022). APOE4 drives inflammation in human astrocytes via TAGLN3 repression and NF-kappaB activation. Cell Reports, 40(7), 111200. https://doi.org/10.1016/j.celrep.2022.111200

Publication types

LinkOut - more resources